Cargando…
Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
Islet transplantation is a well-established therapeutic treatment for a subset of patients with complicated type I diabetes mellitus. Prior to the Edmonton Protocol, only 9% of the 267 islet transplant recipients since 1999 were insulin independent for >1 year. In 2000, the Edmonton group reporte...
Autores principales: | Bruni, Anthony, Gala-Lopez, Boris, Pepper, Andrew R, Abualhassan, Nasser S, Shapiro, AM James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075233/ https://www.ncbi.nlm.nih.gov/pubmed/25018643 http://dx.doi.org/10.2147/DMSO.S50789 |
Ejemplares similares
-
Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation
por: Abualhassan, Nasser, et al.
Publicado: (2016) -
Revascularization of Transplanted Pancreatic Islets and Role of the Transplantation Site
por: Pepper, Andrew R., et al.
Publicado: (2013) -
Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device
por: Pepper, Andrew R., et al.
Publicado: (2015) -
Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site
por: Pepper, Andrew R., et al.
Publicado: (2017) -
Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells
por: Gamble, Anissa, et al.
Publicado: (2018)